PubRank

Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 24535126)

Published in Bone Marrow Transplant on February 17, 2014

Authors

I A Bilmon1, L J Ashton2, R E Le Marsney2, A J Dodds1, T A O'Brien3, L Wilcox4, I Nivison-Smith4, B Daniels5, C M Vajdic5, CAST study group

Author Affiliations

1: Department of Haematology and Stem Cell Transplantation, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
2: Molecular Epidemiology Group, Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Randwick, New South Wales, Australia.
3: Centre for Children's Cancer and Blood Disorders, Sydney Children's Hospital, Randwick, New South Wales, Australia.
4: Australasian Bone Marrow Transplant Recipient Registry, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
5: Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales, Randwick, New South Wales, Australia.

Articles citing this ↘

Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant (2015) 0.86

Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. Haematologica (2015) 0.81

Long-term outcomes following post-operative radiotherapy for Stage I/II testicular seminoma - an Australasian single-institution experience. J Med Radiat Sci (2016) 0.75

Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood. Children (Basel) (2015) 0.75

Melanoma Incidence and Lethality Is Increased Following Solid Organ Transplantation. J Invest Dermatol (2015) 0.75